ConvaTec Group PLC Director Declaration (7477I)
03 Aprile 2020 - 12:00PM
UK Regulatory
TIDMCTEC
RNS Number : 7477I
ConvaTec Group PLC
03 April 2020
ConvaTec Director Declaration
Reading, United Kingdom (3 April 2020)
ConvaTec Group Plc ("ConvaTec" or "the Company") announces that
Dr Ros Rivaz , a Non-Executive Director of the Company, has
accepted a nomination to be appointed to the Board of Aperam S.A. ,
as a Non-Executive Director, subject to a shareholder vote on 5 May
2020.
This announcement is made in accordance with Listing Rule
9.6.14R.
Enquiries
Analysts and Investors
Mark Reynolds, Director Investor Relations, ConvaTec +44 (0)7551 036 625
ir@convatec.com
Media
Buchanan: Charles Ryland / Chris Lane / Vicky Haynes +44 (0)207 466 5000
ConvaTec Group Plc's LEI code is 213800LS272L4FIDOH92
About ConvaTec
ConvaTec is a global medical products and technologies company
focused on therapies for the management of chronic conditions, with
leading market positions in advanced wound care, ostomy care,
continence and critical care, and infusion care. ConvaTec's
products provide a range of clinical and economic benefits
including infection prevention, protection of at-risk skin,
improved patient outcomes and reduced total cost of care. To learn
more about ConvaTec, please visit www.convatecgroup.com where a
copy of this announcement can also be found.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
RDNUPUCACUPUUBW
(END) Dow Jones Newswires
April 03, 2020 06:00 ET (10:00 GMT)
Grafico Azioni Convatec (LSE:CTEC)
Storico
Da Feb 2024 a Mar 2024
Grafico Azioni Convatec (LSE:CTEC)
Storico
Da Mar 2023 a Mar 2024